Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **bile duct** system comprises a branching network of tubes that transport bile from the liver and gallbladder to the duodenum (small intestine)[1][3][5][9]. The network is collectively termed the **biliary tree** and includes intrahepatic ducts (within the liver) and extrahepatic ducts (outside the liver), such as the right and left hepatic ducts, common hepatic duct, cystic duct, and common bile duct. The main biological function is to channel bile—a digestive fluid produced by the liver and stored in the gallbladder—that is essential for digesting fats and absorbing fat-soluble vitamins[1][3][5][9]. Diseases involving the bile ducts, such as cholangiocarcinoma (bile duct cancer), cholangitis (duct inflammation), obstruction, and congenital defects, are significant causes of hepatobiliary morbidity. The bile ducts themselves are not receptors, enzymes, or molecular targets, but rather anatomical structures lined by cholangiocytes (specialized epithelial cells)[7]. Emerging cancer therapies may target molecular alterations in the epithelial cells lining the ducts in diseases like cholangiocarcinoma, but not the duct as a molecular entity[2][4][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bile duct.